August Newsmakers

August 16, 2019
By: Julie Poucher Harbin, Writer, DCI

You might be withholding life-threatening information from your doctor without knowing it (Popular Science)
Features Kathryn Pollak, PhD

Dying Words Aren't What I Imagined (Medium)
Features Nathan Gray, MD

A vegan diet may help boost cancer treatments, study finds (New York Post)
Jason Locasale, PhD

New NCCN Guidelines Are First to Address Small Intestine Cancers; Updates Highlight Developments in Genetic Testing and Hereditary Risk for Colon and Other Intestinal Cancers (NCCN)
Features Dawn Provenzale, MD, MS

Op-Ed: In med school, a mission found me. But it will never be just a job — cancer and grief brought me to it (Los Angeles Times)
Features Fumiko Chino, MD, and Nathan Gray, MD

Raleigh doctor credits his son for helping him fight leukemia (WRAL)
Features David Zaas, MD

Going vegan like Natalie Portman and Ariana Grande may halt cancer in its tracks, study claims (The Sun)
Features Jason Locasale, PhD

AI is improving the accuracy of breast cancer detection (bizwomen)
Features Stanley Robboy, MD

Although Barriers to Treating Brain Metastases Exist, Systemic Therapies Make Progress (Targeted Oncology)
Features Carey Anders, MD

Enzalutamide Plus ADT Reduces Death Risk in Hormone-Sensitive Prostate Cancer (Oncology Learning Network)
Features Andrew Armstrong, MD

Finances Affect Women's Choice of Breast Cancer Treatment: Study (Healthday)
Features Rachel Greenup, MD

Investigators Assess PARP Inhibitor-Abiraterone Combo as Frontline mCRPC Therapy (OncLive)
Features Andrew Armstrong, MD

WATCH: Advancements in Nonmetastatic CRPC (OncLive)
Features Judd Moul, MD

Practical Advice on Follow-Up for Patients with M0 CRPC (OncLive)
Features Judd Moul, MD

Dr. Gasparetto on Key Trials in Relapsed/Refractory Multiple Myeloma (OncLive)
Features Cristina Gasparetto, MD

WATCH: Dr. George on Promise of PARP Inhibitors in Prostate Cancer (OncLive)
Features Daniel George, MD

Tyrosine Kinase Inhibitors Used Alone or in Combination to Treat RCC (OncLive)
Features Daniel George, MD

WATCH: Dr. Chao on Minimal Residual Disease in ALL (OncLive)
Features Nelson Chao, MD

WATCH: A Prognostic Model for Overall Survival in Men with Metastatic Castration-resistant Prostate Cancer - Susan Halabi (Uro Today)
Features Susan Halabi, PhD

WATCH: Molecular Testing and Treatment Decisions in Classical HL (Targeted Oncology)
Features Ahmed Galal, MD

WATCH: Caring For Every Patient And Learning From Every Patient (Oncology Tube)
Features Yousuf Zafar, MD

TKI, Anti-VEGF Drug Combo Does Not Delay EGFR-Mutant NSCLC Progression in Phase II Trial (Precision Oncology News)
Features Thomas E. Stinchcombe, MD

Study Shows How Prostate Cancer Cells Mimic Osteoblasts (Medical Device News)
DCI researchers

Brotman Baty Institute Forms Inaugural Scientific Advisory Board (Press Release)
Features Geoffrey Ginsburg, MD, PhD

Despite treatment, elderly cancer patients have worse outcomes if HIV-positive (H. Lee Moffitt Cancer Center & Research Institute)
Features Duke University researchers

MonaLisa Laser Is New Treatment for Vaginal Dryness (Duke Health Blog)
Features Susann Clifford, MD

How Do Whales Fight Off Cancer? Scholar in Duke’s Marine Medicine Program Breaks New Ground In This Fascinating Inquiry (Duke SoM Magnify)
Features Jason Somarelli, PhD, Serene Cheng

Toxic Shock: Cancer Care Leaves Patients' Families Drowning in Debt, Even After Death (Duke Today)
Features Fumiko Chino, MD, and Nathan Gray, MD

Employee Athletes Among Us (Duke Today)
Features Rochelle Schwartz-Bloom, PhD

Alumni Profiles Series: Shweta Krishnan (Duke Graduate School Professional Development Blog)
Features Shweta Krishnan, PhD

Students in the Field: Yadurshini Raveendran (Duke Global Health Institute Blog)
Features Kristin Schroeder, MD

Papers

Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set. JCO Clinical Cancer Informatics. August 12, 2019. Sandra D. Griffith, PhD; Rebecca A. Miksad, MD, MPH; Geoff Calkins; Paul You, MPH; Nicole G. Lipitz; Ariel B. Bourla, MD, PhD; Erin Williams; Daniel J. George, MD; Deborah Schrag, MD; Sean Khozin, MD, MPH; William B. Capra, PhD; Michael D. Taylor, PhD, PharmD; and Amy P. Abernethy, MD, PhD.

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non–Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncology. August 8, 2019. Thomas E. Stinchcombe, MD; Pasi A. Jänne, MD, PhD; Xiaofei Wang, PhD; Erin M. Bertino, MD; Jared Weiss, MD; Lyudmila Bazhenova, MD; Lin Gu, MS; Christie Lau, BSc; Cloud Paweletz, PhD; Anthony Jaslowski, MD; Gregory J. Gerstner, MD; Maria Q. Baggstrom, MD; Stephen Graziano, MD; James Bearden III, MD; Everett E. Vokes, MD.

HIV Infection, Cancer Treatment Regimens, and Cancer Outcomes Among Elderly Adults in the United States. JAMA Oncology. August 1, 2019. Anna E. Coghill, PhD, MPH; Gita Suneja, MD; Anne F. Rositch, PhD; Meredith S. Shiels, PhD; Eric A. Engels, MD.

Democratizing Cancer Diagnostics and Therapeutics Through Precision Medicine. Technology & Innovation (National Academy of Inventors). August 2019. Ramanujam, Nimmi; Crouch, Brian.

Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets. Journal of Gastrointestinal Oncology. 2019. Benjamin A. Weinberg, Joanne Xiu, Michael R. Lindberg, Anthony F. Shields, Jimmy J. Hwang, Kelsey Poorman, Mohamed E. Salem, Michael J. Pishvaian, Randall F. Holcombe, John L. Marshall, Michael A. Morse.

Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature. July 31, 2019. Xia Gao, Sydney M. Sanderson, Ziwei Dai, Michael A. Reid, Daniel E. Cooper, Min Lu, John P. Richie Jr, Amy Ciccarella, Ana Calcagnotto, Peter G. Mikhael, Samantha J. Mentch, Juan Liu, Gene Ables, David G. Kirsch, David S. Hsu, Sailendra N. Nichenametla & Jason W. Locasale.

Nanoparticle augmentation of radiotherapy in sarcoma. July 08, 2019. The Lancet Oncology. Daniel P Nussbaum.

How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya. Journal of Global Oncology. July 1, 2019. Megan J. Huchko, MPH, MD; Ibrahim Saduma; Cinthia Blat, MS; Sandra Oketch; and Elizabeth A. Bukusi, MBChB, MBE, MMed, MPH, PhD.

Female perspectives on male involvementin a human-papillomavirus-based cervicalcancer-screening program in western Kenya. 2019. Konyin Adewumi, Sandra Y. Oketch, Yujung Choi, and Megan J. Huchko.

How I do it: Apalutamide use in non-metastatic castrate resistant prostate cancer. The Canadian Journal of Urology International. June 2019. Moul W. Judd.

Use of Short Messaging Service to Improve Follow-Up for Abnormal Pap Test Results in Minority and Medically Underserved Women in North Carolina: Questionnaire on Attitudes and Acceptability. JMIR Formative Research. June 8, 2019. LaHoma Smith Romocki, MPH, PhD; Andrea Des Marais, MPH ; Leslie Cofie, MA, MPH, PhD; Chelsea Anderson, MPH; Theresa Curington, BSPH; Jennifer Susan Smith, MPH, PhD.